Nuuron
Berlin, GermanyFounded 2023
- Seed
Nuuron is an emerging company with a website currently under development. Limited public information is available about its products, services, market, or mission.
- RaisedTotal raised
- $3.8M
- Oct 2024Latest priced round, Oct 2024
- Seed
- Investors
- 5
- Founded
- 2023
- Employees
- 1–10
reccy insights
Nuuron’s clearest financing milestone was its €3.5 million seed round, announced on Oct 31, 2024, equivalent to approximately $3.81 million. HTGF (High-Tech Gruenderfonds) led the round, with IBB Ventures, Business Angels Club Berlin-Brandenburg e.V., Caesar Ventures, and Kinled Holding also participating. The financing supports a company founded in 2023 and developing the Memory-Pacemaker, described as a non-invasive photonic neurostimulation device intended to help people with Alzheimer’s store and retrieve memories. Nuuron also appeared in a 2025 European healthtech startups-to-watch feature published on Jun 4, 2025, providing a visibility milestone rather than evidence of a product launch or clinical result. Patent-related activity includes filings or publications dated Mar 13, 2023 and Mar 13, 2024 concerning devices and methods for inducing high-frequency brain oscillations. The company’s profile lists one granted patent and one registered trademark.
Written by reccy's AI from company sites, press and funding records · updated Oct 2026
Technology & products
- Memory-Pacemaker
A non-invasive photonic neurostimulation device intended to help people with Alzheimer’s store and retrieve memories.
Funding
- SeedOct 2024$3.8MLed by HTGF (High-Tech Gruenderfonds)
About Nuuron
- Products
- Memory-Pacemaker
- Leadership
- Fabian Queisner, Co-Founder & CEO
- Focus areas
- NeuroTechnology, biotechnology, science and engineering
- Headquarters
- Berlin, Germany
- Founded
- 2023
- Employees
- 1–10
- Patents granted
- 1
- Trademarks
- 1